At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Enbrel-JIA Use Results Survey [All-Case Surveillance]
In Brief
An observational study evaluating Etanercept (genetical recombination) for Juvenile Idiopathic Arthritis. Completed, enrolled 113 participants across 1 site.
Detailed Summary
This surveillance is conducted to survey the followings under the post marketed drug utilization on the patients who are administrated ENBREL as a treatment for active polyarticular JIA. 1. Primary Occurrence status of Adverse Events; incidence of all adverse events, serious adverse events 2. Secondary Factors affecting safety and to confirm the efficacy such as DAS28.
Study Details
Timeline
Interventions
All patients who administrated ENBREL for active polyarticular juvenile idiopathic arthritis (restricted to the case of lack of effect by other treatment) during registered period (2.5 year).